The cannabinoid system: a role in both the homeostatic and hedonic control of eating?

被引:73
作者
Harrold, JA [1 ]
Williams, G [1 ]
机构
[1] Univ Liverpool, Neuroendocrine & Obes Biol Unit, Dept Med, Clin Dept, Liverpool L69 3GA, Merseyside, England
关键词
anandamide; endocannabinoids; 2-arachidonoyl glycerol; SR; 141716; food intake; obesity; reward;
D O I
10.1079/BJN2003942
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Knowledge of the cannabinoid system and its components has expanded greatly over the past decade. There is increasing evidence for its role in the regulation of food intake and appetite. Cannabinoid system activity in the hypothalamus is thought to contribute to the homeostatic regulation of energy balance, under the control of the hormone leptin. A second component of cannabinoid-mediated food intake appears to involve reward pathways and the hedonic aspect of eating. With the cannabinoid system contributing to both regulatory pathways, it presents an attractive therapeutic target for the treatment of both obesity and eating disorders.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 53 条
  • [1] Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209
  • [2] Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
    Arnone, M
    Maruani, J
    Chaperon, F
    Thiebot, MH
    Poncelet, M
    Soubrie, P
    LeFur, G
    [J]. PSYCHOPHARMACOLOGY, 1997, 132 (01) : 104 - 106
  • [3] An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
    Ben-Shabat, S
    Fride, E
    Sheskin, T
    Tamiri, T
    Rhee, MH
    Vogel, Z
    Bisogno, T
    De Petrocellis, L
    Di Marzo, V
    Mechoulam, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (01) : 23 - 31
  • [4] The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
    Bensaid, M
    Gary-Bobo, M
    Esclangon, A
    Maffrand, JP
    Le Fur, G
    Oury-Donat, F
    Soubrié, P
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (04) : 908 - 914
  • [5] Anandamide and diet:: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
    Berger, A
    Crozier, G
    Bisogno, T
    Cavaliere, P
    Innis, S
    Di Marzo, V
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 6402 - 6406
  • [6] Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
    Boger, DL
    Sato, H
    Lerner, AE
    Hedrick, MP
    Fecik, RA
    Miyauchi, H
    Wilkie, GD
    Austin, BJ
    Patricelli, MP
    Cravatt, BF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5044 - 5049
  • [7] Arachidonic acid amide inhibitors of gap junction cell-cell communication
    Boger, DL
    Sato, H
    Lerner, AE
    Guan, XJ
    Gilula, NB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) : 1151 - 1154
  • [8] Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632
  • [9] Calignano A, 1997, EUR J PHARMACOL, V340, pR7
  • [10] Appetite suppression and weight loss after the cannabinoid antagonist SR141716
    Colombo, G
    Agabio, R
    Diaz, G
    Lobina, C
    Reali, R
    Gessa, GL
    [J]. LIFE SCIENCES, 1998, 63 (08) : PL113 - PL117